Delirium in palliative care

ONCOLOGY

Volumn 18, Issue 12, 2004, Pages 1541-1550

  Friedlander, Miriam M ^a   Yanina, Brayman ^b   Breitbart, William S ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; DELIRIUM; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; HOSPITALIZATION; HUMAN; METHODOLOGY; NEOPLASM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; REVIEW; TERMINALLY ILL PATIENT;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DELIRIUM; DEMENTIA; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASMS; PALLIATIVE CARE; SEVERITY OF ILLNESS INDEX; TERMINALLY ILL;

EID: 16644397670     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Brekbart W, Marotta R, Piatt M: A double- blind comparison trial of haloperidol, chlorpro- mazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231-237, 1996.
2. Bruera E, Miller L, McCallion J: Cognitive failure in patients with terminal cancer: A prospective study. J Pain Symptom Manage 7:192-195, 1992.
3. Fainsinger R, Young C: Cognitive failure in a terminally ill patient. J Pain Symptom Manage 6:492-494, 1991.
4. Leipzig R, Goodman H, Gray G: Reversible narcotic associated mental status impairment in patients with metastatic cancer. Pharmacology 35:47-54, 1987.
5. Levine P, Silberfarb P, Lipowski Z: Mental disorders in cancer patients: A study of 100 psychiatric referrals. Cancer 42:1385-1391, 1978.
6. Massie M, Holland J, Glass E: Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048-1050, 1983.
7. Murray G: Confusion, delirium, and dementia, in Hackett T, Cassem N (eds): Massachusetts General Hospital Handbook of General Hospital Psychiatry, pp 84-115. Littleton, Mass, PSG Publishing, 1987.
8. Posner J: Delirium and exogenous metabolic brain disease, in Beeson P, McDermott W, Wyngaarden J (eds): Cecil Textbook of Medicine, pp 644-651. Philadelphia, WB Saunders, 1979.
9. Knight E, Folstein M: Unsuspected emotional and cognitive disturbance in medical patients. Ann Intern Med 87:723-724, 1977.
10. Pereira J, Hanson J, Bruera E: The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 79:835-841, 1997.
11. Lipowski Z: Delirium: Acute confusional states., New York, Oxford, 1990.
12. Tune L: Post-operative delirium. Int Psychogeriatr 3:325-332, 1991.
13. Berman K, Eastham E: Psychogeriatric ascertainment and assessment for treatment in an acute medical ward setting. Aging 3:174-188, 1974.
14. Gillick M, Serrel N, Gillick L: Adverse consequences of hospitalization in the elderly. Soc Sci Med 16:1033-1038, 1982.
15. Hodkinson H: Mental impairment in the elderly. J R Coll Physicians Land 7:305-317, 1973.
16. Seymour D, Henschke P, Cape R: Acute confusional states and dementia in the elderly: The role of dehydration/volume depletion, physical illness, and age. Aging 9:137-146, 1980.
17. Warsaw G, Moore J, Friedman S: Functional disability in the hospitalized elderly. JAMA 248:847-850, 1982.
18. Varsamis J, Zuchowski T, Maini K: Survival rates and causes of death in geriatric psychiatric patients: A six year follow-up study. Can Psychiatr Assoc J 17:17-22, 1972.
19. Breitbart W, Gibson C, Tremblay A: The delirium experience: Delirium recall and delirium related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43:183-194, 2002.
20. Trzepacz P, Teague G, Lipowski Z: Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 7:101-106, 1985.
21. Bruera E, Fainsinger RL, Miller MJ, et al: The assessment of pain intensity in patients with cognitive failure: A preliminary report. J Pain Symptom Manage 7:267-270, 1992.
22. Coyle N, Breitbart W, Weaver S, et al: Delirium as a contributing factor to "crescendo" pain: Three case reports. J Pain Symptom Manage 9:44-47, 1994.
23. ]23. Fainsinger R, MacEachem T, Hanson J: Symptom control during the last week of life in a palliative care unit. J Palliat Care 7:5-11, 1991.
24. Morita T, Tei Y, Inouye S: Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: Prevalence and identification of research focus. J Pain Symptom Manage 26:827-834, 2003.
25. Bruera E, MacMillan K, Hanson J: The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 39:13-16, 1989.
26. Silberfarb P: Chemotherapy and cognitive deficits in patients with cancer. Annu Rev Med 34:35-46, 1983.
27. Stiefel F, Breitbart W, Holland J: Corticosteroids in cancer: Neuropsychiatric complications. Cancer Invest 7:479-491, 1989.
28. Stiefel F, Fainsinger R, Bruera E: Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 7:94-98, 1992.
29. Lawlor P, Gagnon B, Mancini IL, et al: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Medicine 160:786-794, 2000.
30. Wise M, Brandt G: Delirium, in Yudofsky S, Hales R (eds): Textbook of Neuropsychiatry. Washington, DC, American Psychiatric Association, 1992.
31. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.
32. Ross C: CNS arousal systems: Possible role in delirium. Int Psychogeriatr 3:353-371, 1991.
33. Lipowski Z: Delirium: Acute brain failure in man. Springfield, LI, Charles C Thomas, 1980.
34. Ross C, Peyser CE, Shapiro I, et al: Delirium: Phenomenologic and etiologic subtypes. Int Psychogeriatr 3:135-147, 1991.
35. Breitbart W, Bruera E, Chochinov H: Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage 10:131-141, 1995.
36. Beaver W, Wallenstein S, Houde R: A comparison of the analgesic effect of methotrimeprazine and morphine in patients With cancer. Clin Pharmacol Ther 7:436-446, 1966.
37. Walsh T: Adjuvant analgesic therapy in cancer pain, in Foley K, Bonica J, Ventafridda V (eds): Advances in Pain Research and Therapy, pp 155-166. 1990, New York, Raven Press, 1990.
38. Albert M, Levkoff S, Reilley C: The delirium symptom interview: An interview for the detection of delirium symptoms in hospitalized patients. J Geriatr Psychiatry Neurol 5:14-21, 1991.
39. Breitbart W, Rosenfeld B, Roth A: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 13:128-137, 1997.
40. Folstein M, Folstein S, McHugh P: "Mini-Mental Status": A practical method for grading the cognitive state of patients for clinicians. J Psychiatr Res 12:189-198, 1975.
41. Jacobs JW, Bemhard MR, Delgado A, et al: Screening for organic mental syndromes in the medically ill. Ann Intern Med 86:40-46, 1977.
42. Katzman R, Brown T, Fuld P: Validation of a short orientation-memory- concentration test of cognitive impairment. Am J Psychiatry 140:734-739, 1983.
43. Levkoff S, Liptzin B, Cleary P: Review of research instruments and techniques to detect delirium. Int Psychogeriatr 3:253-272, 1992.
44. Trzepacz P, Baker R, Greenhouse J: A symptom rating scale of delirium. Psychiatry Res 23:89-97, 1988.
45. Williams M: Delirium/acute confusional states: Evaluation devices in nursing. Int Psychogeriatr 3:301-308, 1991.
46. Wolber G, Romaniuk M, Eastman E, et al: Validity of the Short Portable Mental Status Questionaire with elderly psychiatric patients. J Consult Clin Psychol 52:712-713, 1984.
47. Smith M, Breitbart W, Plan M: A critique of instruments and methods to detect, diagnose and rate delirium. J Pain Symptom Manage 10:35-77, 1995.
48. Trzepacz P et al: Validity of the Delirium Rating Scale-Revised 98 (DRS.98). Proceedings of the 46th Annual Meeting of the Academy of Psychosomatic Medicine. New Orleans, 1999.
49. Inouye B, Vandyck C, Alessi C: Clarifying confusion: The confusion assessment method, a new method for the detection of delirium. Ann Intern Med 113:941-948, 1990.
50. Hart R, Best AM, Sessler CN, et al: Abbreviated cognitive test for delirium. J Psychosom Res 43:417-423, 1997.
51. Lawlor P, Nekolaichuk C, Gagnon B, et al: Clinical utility, factor analysis and further validation of the Memorial Delirium Assessment Scale (MDAS). Cancer 88:2859-2867, 2000.
52. American Psychiatric Association: Practice guidelines for the treatment of patients with delirium. Am J Psychiatry 156:S1-S20, 1999.
53. Lichter I, Hunt E: The last 24 hours of life. J Palliat Care 6(4):7-15, 1990.
54. Fainsinger R, Bruera E: Tretment of delirium in a terminally ill patient. J Pain Symptom Manage 7:54-56, 1992.
55. Adams F, Quesada J, Gutterman J: Neu- ropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA 252:939-941, 1984.
56. DeAngelis L, Delattre J, Posner J: Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789-796, 1989.
57. Denicoff K, Rubinow D, Papa M: The neuropsychiatric effects of treatment with interIeukin-2 and lymphokine-activated killer cells. Ann Intern Med 107:293-300, 1987.
58. Holland J, Fasanello S, Ohnuma T: Psychiatric symptoms associated with L-asparaginase administration. J Psychiatr Res 10:105-113, 1974.
59. Weddington W: Delirium and depression associated with amphotericin B. Psychosomatics 23:1076-1078, 1982.
60. Young D: Neurological complications of cancer chemotherapy, in Silverstein A (ed): Neurological Complications of Therapy: Selected Topics, pp 57-113. New York, Futura, 1982.
61. Inouye SK, Bogardus ST Jr, Charpentier PA, et al: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340:669-676, 1999.
62. Derogatis L, Feldstein M, Morrow G: A survey of psychotropic drug prescriptions in an oncology population. Cancer44:1919-1929, 1979.
63. Stiefel F, Kornblith A, Holland J: Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10 year period. Cancer 65:1048-1053, 1990.
64. Goldberg G, Mor V: A survey of psychotropic use in terminal cancer patients. Psy- chosomatics 26:745-751, 1985.
65. Jaeger H, Morrow G, Brescia F: A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp Psychiatry 7:353-360, 1985.
66. Akechi T, Uchitomi Y, Okamura H: Usage of haloperidol for delirium in cancer patients. Support Cancer Care 4:390-392, 1996.
67. Chochinov H, Breitbart W (eds): Handbook of Psychiatry in Palliative Medicine. New York, Oxford University Press, 2000.
68. Fernandez F, Holmes VF, Adams F, et al: Treatment of severe refractory agitation with a haloperidol drip. J Clin Psychiatry 49:239-241, 1988.
69. Fernandez F, Levy J, Mansell P: Management of delirium in terminally ill AIDS patients. Int J Psychiatry Med 19:165-172, 1989.
70. Rosen J: Double-blind comparison of haloperidol and thioridazine in geriatric outpatients. J Clin Psychiatry 40:17-20, 1979.
71. Smith G, Taylor C, Linkons P: Haloperidol versus thioridazine for the treatment of psychogeriatric patients: A double-blind clinical trial. Psychosomatics 15:134-138, 1974.
72. Thomas H Jr, Schwartz E, Petrilli R: Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann EmergMed 21:407-413, 1992.
73. Tsuang MM, Lu LM, Stotsky BA, et al: Haloperidol versus thioridazine for hospitalized psychogeriatric patients: Double-blind study. J Am Geriatr See 19:593-600, 1971.
74. Breitbart W: Psychiatric management of cancer pain. Cancer 63:2336-2342, 1989.
75. Twycross R, Lack S: Symptom Control in Far Advanced Cancer: Pain Relief. London, Pitman, 1983.
76. Breitbart W: Diagnosis and management of delirium in the terminally ill, in Portenoy R, Bruera E (eds): Topics in Palliative Care, pp 303-321. New York, Oxford University Press, 2001.
77. Menza M, Murray G, Holmes V: Controlled study of extrapyramidal reactions in the management of delirious medically ill patients: Intravenous haloperidol versus haloperidol plus benzodiazepines. Heart Lung 17:238-241, 1988.
78. Oliver D: The use of methotrimeprazine in terminal care. Br J Clin Pract 39:339-340, 1985.
79. Baldessarini R, Frankenburg F: Clozapine: A novel antipsychotic agent. N EngJ J Med 324:746-752, 1991.
80. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43:175-176, 2002.
81. Passik S, Cooper M: Complicated delirium in a cancer patient successfully treated with olanzapine. J Pain Symptom Manage 17:219-223, 1999.
82. Sipahimalani A, Sime R, Massand P: Treatment of delirium with risperidone. Int J Geriatric Psychopharmacology 1:24-26, 1997.
83. Sipahimalani A, Massand P: Olanzapine in the treatment of delirium. Psychosomatics 39:422-430, 1998.
84. Han C, Kim Y: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45:297-301, 2004.
85. Breitbart W, Chochinov H, Passik S: Psychiatric aspects of palliative care, in Doyle D, Hanks G, MacDonald N (eds): Oxford Textbook of Palliative Medicine, pp 933-954. New York, Oxford University Press, 1998.
86. Ventafridda V, Ripamonti C, DeConno F: Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7-11, 1990.
87. Bottomley D, Hanks G: Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage 5:259-261, 1990.
88. Mercadante S, DeConno F, Ripamonti C: Propofol in terminal care. J Pain Symptom Manage 10:639-642, 1995.
89. Moyle J: The use of propofol in palliative medicine. J Pain Symptom Manage 10:643-646, 1995.